object
intern
consensu
reach
empir
use
antibiot
atyp
coverag
nurs
homeeacquir
pneumonia
nhap
aspir
import
caus
nhap
may
requir
antimicrobi
treatment
studi
aim
investig
preval
clinic
characterist
ap
infect
review
need
empir
antibiot
atyp
coverag
nhap
design
prospect
cohort
studi
set
four
nurs
home
total
number
resid
particip
patient
age
year
hospit
nhap
defin
presenc
respiratori
symptom
abnorm
chest
radiograph
april
march
measur
demograph
clinic
paramet
investig
result
record
microbi
investig
compris
sputum
routin
mycobacteri
cultur
blood
urin
cultur
serolog
nasopharyng
aspir
viral
cultur
polymeras
chain
reaction
test
suspect
aspir
pneumon
arbitrarili
defin
nhap
without
pathogen
identifi
result
exclud
lone
bacteriuria
episod
nhap
patient
includ
twelv
ap
detect
patient
clinic
featur
distinguish
infect
caus
ap
pathogen
commonest
ap
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
detect
urinari
antigen
test
none
patient
ap
infect
receiv
antibiot
indic
ap
infect
howev
ap
infect
result
mortal
pathogen
isol
case
patient
without
pathogen
isol
less
like
purul
sputum
crepit
chest
auscult
compar
pneumonia
caus
identifi
pathogen
conclus
atyp
pathogen
ap
associ
mortal
even
case
prescrib
antibiot
cover
ap
nhap
may
necessarili
treat
empir
antibiot
cover
ap
pneumonia
common
caus
death
among
nurs
home
resid
streptococcu
pneumonia
haemophilu
influenza
commonest
bacteri
pathogen
patient
abl
expector
aspir
import
contribut
factor
aspir
pneumon
caus
chemic
injuri
lung
parenchyma
without
bacteri
infect
necessit
antibiot
treatment
contrast
aspir
pneumonia
caus
bacteri
pathogen
oropharynx
includ
gramneg
bacilli
staphylococcu
aureu
anaerob
bacteria
commonli
isol
intub
patient
aspir
pneumon
difficult
differenti
pneumonia
clinic
empir
use
antibiot
regimen
cover
atyp
pathogen
ap
manag
communityacquir
pneumonia
cap
adult
controversi
accord
cochran
systemat
review
empir
use
antibiot
atyp
coverag
compar
without
atyp
coverag
provid
surviv
benefit
clinic
efficaci
patient
hospit
lowsever
pneumonia
british
thorac
societi
guidelin
howev
recommend
empir
use
combin
regimen
penicillin
macrolid
antibiot
patient
hospit
moderateto
highsever
pneumonia
infecti
diseas
societi
americaamerican
thorac
societi
guidelin
recommend
empir
use
antibiot
atyp
coverag
nurs
homeeacquir
pneumonia
nhap
import
ap
mycoplasma
pneumonia
chlamydophila
spp
coxiella
burnetii
legionella
pneumophila
older
patient
pneumonia
unclear
ap
like
infect
older
peopl
multipl
comorbid
younger
one
common
cap
nhap
littl
inform
regard
preval
mortal
ap
infect
nhap
cap
major
determin
factor
empir
use
antibiot
regimen
atyp
coverag
inform
need
establish
role
ap
l
pneumophila
nhap
perform
subgroup
analysi
nhap
studi
influenzalik
ill
ili
old
peopl
live
nurs
home
studi
aim
investig
preval
clinic
characterist
ap
infect
nhap
review
need
empir
antibiot
therapi
atyp
coverag
nhap
methodolog
studi
describ
elsewher
four
nurs
home
locat
shatin
district
hong
kong
total
number
resid
particip
studi
april
march
research
staff
liais
nurs
doctor
commun
geriatr
outreach
team
hong
kong
hospit
author
identifi
resid
ili
everi
day
ili
episod
defin
fever
c
f
oral
temperatur
acut
deterior
physic
mental
condit
plu
either
new
onset
one
respiratori
symptom
acut
worsen
chronic
condit
involv
respiratori
symptom
chest
radiograph
taken
chronic
cough
last
week
taken
pneumonia
suspect
respiratori
urinari
specimen
collect
within
first
day
ill
serolog
week
later
matter
whether
patient
hospit
nurs
home
patient
ili
manag
physician
commun
geriatr
outreach
team
nurs
home
resid
hospit
critic
ill
condit
could
longer
manag
nurs
home
followup
visit
arrang
research
nurs
recoveri
ill
studi
approv
research
ethic
committe
chines
univers
hong
kong
appropri
inform
written
consent
obtain
patient
proxi
patient
ili
symptom
follow
specimen
collect
microbi
investig
sputum
blood
urin
sampl
nasopharyng
aspir
npa
serolog
sputum
sampl
use
routin
bacteri
cultur
cover
pneumonia
h
influenza
moraxella
catarrhali
pseudomona
spp
pathogen
sputum
mycobacteri
cultur
tuberculosi
limit
prolong
respiratori
symptom
weight
loss
hospit
admiss
npa
sampl
sent
routin
viral
cultur
includ
influenza
b
parainfluenza
viru
type
respiratori
syncyti
viru
adenoviru
rapid
multiplex
nest
polymeras
chain
reaction
pcr
undertaken
detect
atyp
organ
pneumonia
c
pneumonia
l
pneumophila
virus
influenza
b
parainfluenza
viru
type
respiratori
syncyti
viru
rhinoviru
adenoviru
enteroviru
coronaviru
metapneumoviru
pair
serum
sampl
taken
identifi
ap
pneumonia
chlamydophila
spp
c
burnetii
l
pneumophila
respiratori
virus
influenza
b
parainfluenza
adenoviru
complement
fixat
test
blood
urin
sampl
collect
routin
cultur
urinari
antigen
test
l
pneumophila
serogroup
pneumonia
perform
hospit
patient
nhap
defin
presenc
respiratori
symptom
support
abnorm
find
chest
radiograph
illdefin
shadow
consolid
pleural
effus
studi
recruit
resid
hospit
nhap
caus
nhap
definit
one
follow
criteria
met
follow
characterist
studi
patient
record
demograph
characterist
comorbid
vaccin
statu
prior
hospit
premorbid
function
statu
miniment
state
examin
bodi
mass
index
symptom
sign
ill
investig
result
antibiot
hospit
length
stay
mortal
premorbid
function
statu
assess
barthel
index
score
cover
wide
rang
activ
daili
live
total
score
score
indic
independ
indic
mild
moder
function
limit
indic
sever
limit
burden
medic
ill
repres
charlson
comorbid
index
sever
pneumonia
measur
curb
score
confus
blood
urea
level
respiratori
rate
low
blood
pressur
categor
variabl
express
count
percentag
continu
variabl
mean
ae
sd
median
interquartil
rang
two
group
compar
c
fisher
exact
test
categor
variabl
test
mannewhitney
u
test
continu
variabl
twotail
test
signific
level
use
analys
statist
packag
social
scienc
spss
inc
chicago
illinoi
use
statist
analys
total
episod
ili
occur
patient
abnorm
chest
radiograph
present
episod
except
one
requir
hospit
two
episod
exclud
miss
data
remain
episod
bacteria
isol
urin
sampl
episod
exclud
final
episod
nhap
patient
includ
studi
clinic
characterist
investig
result
studi
popul
list
tabl
sputum
routin
mycobacteri
cultur
perform
patient
respect
npa
sampl
collect
patient
pcr
test
patient
viral
cultur
pair
serolog
avail
patient
urinari
antigen
test
l
pneumophila
pneumonia
carri
patient
blood
urin
sampl
collect
routin
cultur
patient
caus
factor
establish
patient
microbi
find
summar
tabl
concomit
bacteriuria
found
patient
studi
patient
belong
categori
pneumonia
unknown
etiolog
pathogen
identifi
despit
extens
microbi
investig
respiratori
urinari
pathogen
acut
inflammatori
condit
lower
respiratori
tract
like
caus
aspir
pneumon
aspir
pneumonia
similar
percentag
patient
without
nasogastr
tube
feed
repres
vs
p
patient
treat
empir
antibiot
admiss
group
patient
lower
inhospit
mortal
rate
pathogen
identifi
although
statist
signific
reach
vs
p
presenc
purul
sputum
crepit
chest
auscult
featur
distinguish
patient
without
pathogen
identifi
list
tabl
preval
rate
ap
infect
nhap
commonest
ap
pneumonia
c
pneumonia
coinfect
virus
bacteria
occur
five
urinari
antigen
test
detect
l
pneumophila
differ
clinic
characterist
pneumonia
caus
ap
pathogen
tabl
atyp
isol
cluster
time
specif
facil
one
except
none
patient
ap
infect
treat
antibiot
cover
ap
hospit
patient
treat
levofloxacin
admiss
allergi
penicillin
patient
receiv
penicillin
antibiot
ap
infect
result
death
overal
inhospit
mortal
rate
studi
popul
studi
demonstr
ap
import
caus
nhap
reflect
low
preval
lack
antibiot
treatment
atyp
coverag
result
mortal
despit
advanc
technolog
avail
multiplex
pcr
detect
common
pathogen
npa
specimen
caus
nhap
could
identifi
case
aspir
pneumon
presum
account
case
preval
rate
ap
infect
studi
greater
find
previou
studi
reliabl
clinic
characterist
differenti
nahp
caus
ap
pathogen
combin
use
npa
pcr
test
tradit
serolog
like
contribut
greater
preval
ap
infect
studi
pneumonia
c
pneumonia
infect
diagnos
exclus
npa
pcr
test
serolog
meanwhil
chlamydophila
c
burnetii
detect
serolog
patient
ap
infect
surviv
wherea
one
receiv
antibiot
cover
ap
anoth
studi
also
show
ap
infect
result
lower
mortal
pathogen
although
differ
statist
signific
vs
p
hypothes
ap
caus
pneumonia
milder
sever
clinic
cours
usual
selflimit
without
antibiot
therapi
even
older
peopl
lower
immun
thu
recommend
antibiot
atyp
coverag
use
empir
nhap
legionella
infect
acquir
inhal
contamin
aerosol
produc
water
system
cool
tower
shower
hot
water
distribut
system
aspir
contamin
water
anoth
rout
transmiss
hot
humid
environ
facilit
format
biofilm
subsequ
growth
l
pneumophila
water
tank
pipe
environ
predispos
prolifer
bacterium
commonli
encount
hong
kong
especi
nurs
home
set
howev
previou
studi
show
l
pneumophila
rare
pathogen
nhap
studi
confirm
rariti
legionella
infect
nhap
base
result
urinari
antigen
test
perform
nearli
studi
patient
find
support
recommend
empir
antibiot
atyp
coverag
indic
routin
nhap
basi
local
data
urinari
antigen
test
l
pneumophila
would
part
routin
workup
nhap
low
costeffect
aspir
pneumon
clinic
diagnosi
exclus
signific
caus
nhap
studi
suggest
nurs
home
resid
pneumonia
pathogen
identifi
purul
sputum
chest
crepit
examin
case
could
caus
aspir
pneumon
difficult
clinic
distinguish
aspir
pneumon
aspir
pneumonia
especi
initi
assess
advis
adopt
deescal
approach
refrain
prescrib
prolong
empir
antibiot
patient
bulbar
dysfunct
aspir
pneumon
would
help
reduc
antibiot
resist
cost
unnecessari
antibiot
studi
limit
first
nurs
home
chosen
close
princ
wale
hospit
easi
quick
transport
specimen
second
incid
atyp
infect
may
vari
time
place
experi
may
applic
set
legionnair
diseas
may
endem
facil
water
suppli
colon
chlamydophila
infect
may
caus
local
outbreak
third
examin
relationship
patient
swallow
abil
aspir
pneumon
fourth
definit
aspir
pneumon
arbitrari
studi
patient
without
pathogen
identifi
necessarili
meet
classic
definit
aspir
pneumon
sudden
onset
choke
vomit
fifth
although
npa
blood
serolog
collect
major
patient
patient
could
cough
sputum
suitabl
routin
cultur
mycobacteri
cultur
respect
studi
shown
overal
inhospit
mortal
rate
studi
popul
nhap
wherea
ap
neither
common
caus
nhap
signific
caus
mortal
patient
ap
isol
receiv
antibiot
cover
ap
thu
patient
nhap
requir
empir
antibiot
treatment
atyp
coverag
